Log in


International Society for antiviral research

The International Society for Antiviral Research (ISAR) was formally established on May 14, 1987. After many years of skepticism, antiviral chemotherapy had become a reality and there was a need for investigators in the field to periodically assemble with colleagues to exchange information and set up collaborations. ISAR was established to meet this need. In the spring of 1988, a meeting in Williamsburg, Virginia - The International Conference on Antiviral Research - drew more than 400 participants. Following the meeting, the new Society's membership rolls approached 700. It was clear that those in the antiviral research community welcomed the opportunity to have a forum for the exchange of scientific information.

Since those early beginnings, ISAR has become internationally recognized as an organization for scientist in the field and as offering the premiere scientific meeting on antiviral research. The purpose of ISAR's annual meeting is to provide an interdisciplinary forum at which investigators involved in basic, applied, and clinical research worldwide can meet to review recent developments in all areas of antiviral research. The organizers plan a program to meet the needs of chemists, biologists, virologists and clinicians interested in the field.

The current membership of the International Society for Antiviral Research is a Who's Who of scientists involved in antiviral research. 

ISAR Board of Directors

Officers

PRESIDENT:   Luis M. Schang - 2028

PRESIDENT ELECT:  David Durantel - 2030

IMMEDIATE PAST PRESIDENT:  
Kathie Seley-Radtke - 2026

TREASURER : Brian Gowen - 2027

SECRETARY : Jinhong Chang - 2025

Board Members

Andrea Brancale - 2025

Rhonda Cardin - 2027

Angela Corona - 2026

Cybele Garcia - 2027

Zlatko Janeba - 2025

Chris Meier - 2026

ISAR Committees

ARCHIVE COMMITTEE: Brian Gentry

CAREER DEVELOPMENT COMMITTEE: Rob Jordan (Chair)

    COMMUNICATIONS & OUTREACH COMMITTEE :  Luis M. Schang (Chair)

    • Website workgroup:  Andrea Brancale (Chair)
    • Social media workgroup:  Marco Vignuzzi (Chair)
    • Publication workgroup:  Rob Jordan and Jessica Spengler (Co-Chairs)
    • External Liaisons program:  TBD

    CONFERENCE SPONSORS COMMITTEE : David Durantel (Chair)

    DIVERSITY COMMITTEE: J. Victor Garcia-Martinez (Chair)

    FINANCE COMMITTEE:  David Durantel (Chair)

    NOMINATIONS COMMITTEE :  Katherine Seley-Radtke (Chair), Kara Carter, David Durantel, Luis M. Schang

    POSTER AWARD COMMITTEE: Leen Delang (Chair)

    PROGRAM COMMITTEE:  David Durantel (Chair), Luis M. Schang, Brian Gowen, Andrea Brancale, Jessica Spengler, Jinhong Chang,  Katherine Seley-Radtke, Brian Gentry, Joana Rocha Pereira 

    • Abstract Review Workgroup:  Brian Gentry and Joana Rocha Pereira (Co-Chairs)

    SCIENTIFIC EXCELLENCE AWARDS COMMITTEE: Richard Whitley (Chair)

    THE CHU FAMILY FOUNDATION SCHOLARSHIP FOR WOMEN SCIENTISTS COMMITTEE: Katherine Seley-Radtke (Chair) and Chris Meier (Co-Chair)

    TRAVEL GRANTS COMMITTEE : Jinhong Chang (Chair) and Joana Rocha Pereira (Co-Chair)

    WOMEN IN SCIENCE COMMITTEE: Rhonda Cardin (Chair)

    About ISAR

    The International Society for Antiviral Research (ISAR) is an internationally recognized organization for scientists involved in basic, applied, and clinical aspects of antiviral research. The Society main event is the annual International Conference on Antiviral Research (ICAR), a truly interdisciplinary meeting which attracts the interest of chemists, biologists, and clinicians.

    ISAR

    info@isaricar.com
    1-571-349-0079


    Powered by Wild Apricot Membership Software